Tag Archives: branded generics

China crackdowns squeeze pharma margins

Posted on May 25, 2014 by Alexander Szewczak

From Reuters: A crackdown on corruption and pricing in China’s fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over. Over the … Continue reading →

Posted in Pharmaceutical Industry | Tagged , , | Leave a comment

Pharma companies consider selling off mature drug portfolios

Posted on May 5, 2014 by Alexander Szewczak

As big shifts in the Pharmaceutical industry continue, Reuters is reporting that several large pharma companies, including Abbott, Merck and Sanofi, are considering selling off their portfolios of compounds that have lost patent protection.  From a pharma company’s perspective, branded … Continue reading →

Posted in Pharmaceutical Industry | Tagged , | 1 Comment